A novel approach of organ preservation using anti-necrosis agent before transplantation.

Project Information

ELAPHARMA

Grant agreement ID: 876634

DOI 10.3030/876634

Project closed

EC signature date 2 August 2019

Start date 1 September 2019

End date 31 December 2019

Funded under

• INDUSTRIAL LEADERSHIP - Innovation In SMEs

Total cost € 71 429,00

EU contribution € 50 000,00

Coordinated by

ELA PHARMA LTD
Israel